EPISODE · Mar 9, 2021 · 12 MIN
Halberd’s CEO on The Stock Day Podcast Breaking Down 20X Neutralizing Affinity SARS-COV-2 Antibody
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Halberd Corporation (OTC PINK:HALB)(“the Company”), a company that holds the exclusive rights to the patented extracorporeal treatment technology and the provisional patent applications associated with Covid-19. CEO and Chairman of the Company, William A Hartman, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
The Stock Day Podcast welcomed Halberd Corporation (OTC PINK:HALB)(“the Company”), a company that holds the exclusive rights to the patented extracorporeal treatment technology and the provisional patent applications associated with Covid-19. CEO and Chairman of the Company, William A Hartman, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
Halberd’s CEO on The Stock Day Podcast Breaking Down 20X Neutralizing Affinity SARS-COV-2 Antibody
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m